CA1177420A - Vehicules de clonage - Google Patents

Vehicules de clonage

Info

Publication number: CA1177420A
Authority: CA; Canada
Prior art keywords: plasmid; dna; bacterial; pro1600; rings
Prior art date: 1980-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000423778A

Other languages

English (en)

Inventor

Ronald H. Olsen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Microlife Technics Inc

Original Assignee

Microlife Technics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-05-08

Filing date

1983-03-16

Publication date

1984-11-06

1980-05-08 Priority claimed from US06/147,563 external-priority patent/US4374200A/en

1983-03-16 Application filed by Microlife Technics Inc filed Critical Microlife Technics Inc

1983-03-16 Priority to CA000423778A priority Critical patent/CA1177420A/fr

1984-11-06 Application granted granted Critical

1984-11-06 Publication of CA1177420A publication Critical patent/CA1177420A/fr

Status Expired legal-status Critical Current

Links

239000013612 plasmid Substances 0.000 title claims abstract description 275
238000010367 cloning Methods 0.000 title claims abstract description 36
108020004414 DNA Proteins 0.000 claims abstract description 138
230000001580 bacterial effect Effects 0.000 claims abstract description 78
239000012634 fragment Substances 0.000 claims abstract description 58
238000000034 method Methods 0.000 claims abstract description 53
241000894006 Bacteria Species 0.000 claims abstract description 48
230000008569 process Effects 0.000 claims abstract description 37
102000053602 DNA Human genes 0.000 claims abstract description 31
101100300704 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) queF gene Proteins 0.000 claims abstract description 23
241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 17
101100112724 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) ccsB gene Proteins 0.000 claims abstract description 14
210000000349 chromosome Anatomy 0.000 claims abstract description 7
239000000126 substance Substances 0.000 claims abstract description 7
210000004027 cell Anatomy 0.000 claims description 31
108091008146 restriction endonucleases Proteins 0.000 claims description 26
230000010076 replication Effects 0.000 claims description 9
238000007792 addition Methods 0.000 claims description 7
108010042407 Endonucleases Proteins 0.000 claims description 5
102000004533 Endonucleases Human genes 0.000 claims description 5
230000032823 cell division Effects 0.000 claims description 5
102000003960 Ligases Human genes 0.000 claims description 3
108090000364 Ligases Proteins 0.000 claims description 3
239000003981 vehicle Substances 0.000 claims 2
238000010353 genetic engineering Methods 0.000 abstract description 4
238000011160 research Methods 0.000 abstract description 2
241000364057 Peoria Species 0.000 abstract 1
230000002068 genetic effect Effects 0.000 description 31
229960003669 carbenicillin Drugs 0.000 description 30
FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 30
238000002474 experimental method Methods 0.000 description 20
230000003115 biocidal effect Effects 0.000 description 19
108090000623 proteins and genes Proteins 0.000 description 18
239000004098 Tetracycline Substances 0.000 description 17
229960002180 tetracycline Drugs 0.000 description 17
229930101283 tetracycline Natural products 0.000 description 17
235000019364 tetracycline Nutrition 0.000 description 17
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 16
150000003522 tetracyclines Chemical class 0.000 description 16
230000012010 growth Effects 0.000 description 15
101100407030 Arabidopsis thaliana PAO2 gene Proteins 0.000 description 14
229940024606 amino acid Drugs 0.000 description 14
235000001014 amino acid Nutrition 0.000 description 14
150000001413 amino acids Chemical class 0.000 description 14
230000009466 transformation Effects 0.000 description 14
230000029087 digestion Effects 0.000 description 12
238000012423 maintenance Methods 0.000 description 11
239000002609 medium Substances 0.000 description 11
108020004511 Recombinant DNA Proteins 0.000 description 10
238000005516 engineering process Methods 0.000 description 10
238000000338 in vitro Methods 0.000 description 10
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 9
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
229960000310 isoleucine Drugs 0.000 description 9
229960004452 methionine Drugs 0.000 description 9
229960004295 valine Drugs 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
238000004458 analytical method Methods 0.000 description 7
230000010310 bacterial transformation Effects 0.000 description 7
238000003776 cleavage reaction Methods 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
230000007017 scission Effects 0.000 description 7
229930182844 L-isoleucine Natural products 0.000 description 6
239000013611 chromosomal DNA Substances 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
230000002503 metabolic effect Effects 0.000 description 6
230000006798 recombination Effects 0.000 description 6
238000005215 recombination Methods 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 5
229930195722 L-methionine Natural products 0.000 description 5
238000000246 agarose gel electrophoresis Methods 0.000 description 5
230000002776 aggregation Effects 0.000 description 5
238000004220 aggregation Methods 0.000 description 5
230000021615 conjugation Effects 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
241000894007 species Species 0.000 description 5
238000012546 transfer Methods 0.000 description 5
230000017105 transposition Effects 0.000 description 5
108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 4
230000004543 DNA replication Effects 0.000 description 4
241000589516 Pseudomonas Species 0.000 description 4
239000002253 acid Substances 0.000 description 4
239000013599 cloning vector Substances 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
229930027917 kanamycin Natural products 0.000 description 4
229960000318 kanamycin Drugs 0.000 description 4
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
229930182823 kanamycin A Natural products 0.000 description 4
238000013507 mapping Methods 0.000 description 4
229930182817 methionine Natural products 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
241000589776 Pseudomonas putida Species 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
210000003578 bacterial chromosome Anatomy 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000006872 improvement Effects 0.000 description 3
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
235000014705 isoleucine Nutrition 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
239000000725 suspension Substances 0.000 description 3
241000557626 Corvus corax Species 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000000721 bacterilogical effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
230000030414 genetic transfer Effects 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000013011 mating Effects 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
230000003362 replicative effect Effects 0.000 description 2
230000001568 sexual effect Effects 0.000 description 2
238000005549 size reduction Methods 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
239000004474 valine Substances 0.000 description 2
229920001817 Agar Polymers 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
101000596275 Bacillus subtilis Type II restriction enzyme BglI Proteins 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
241001643623 Enteles Species 0.000 description 1
241001517310 Eria Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
241001646716 Escherichia coli K-12 Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
241000428533 Rhis Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
244000292604 Salvia columbariae Species 0.000 description 1
235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
235000001498 Salvia hispanica Nutrition 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000006790 cellular biosynthetic process Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229910052729 chemical element Inorganic materials 0.000 description 1
235000014167 chia Nutrition 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000009795 derivation Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000002224 dissection Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000005304 joining Methods 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
244000045947 parasite Species 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
230000000243 photosynthetic effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
235000010333 potassium nitrate Nutrition 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
WKQCYNCZDDJXEK-UHFFFAOYSA-N simalikalactone C Natural products C1C(C23C)OC(=O)CC3C(C)C(=O)C(O)C2C2(C)C1C(C)C=C(OC)C2=O WKQCYNCZDDJXEK-UHFFFAOYSA-N 0.000 description 1
239000002689 soil Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
BGRJTUBHPOOWDU-UHFFFAOYSA-N sulpiride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-UHFFFAOYSA-N 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
238000000844 transformation Methods 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
239000013598 vector Substances 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Landscapes

Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA000423778A 1980-05-08 1983-03-16 Vehicules de clonage Expired CA1177420A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000423778A CA1177420A (fr)	1980-05-08	1983-03-16	Vehicules de clonage

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US147,563		1980-05-08
US06/147,563 US4374200A (en)	1980-05-08	1980-05-08	Broad host range small plasmid rings as cloning vehicles
CA000355182A CA1150169A (fr)	1980-05-08	1980-06-30	Anneaux de plasmides comme vehicule de clonage
CA000423778A CA1177420A (fr)	1980-05-08	1983-03-16	Vehicules de clonage

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000355182A Division CA1150169A (fr)	1980-05-08	1980-06-30	Anneaux de plasmides comme vehicule de clonage

Publications (1)

Publication Number	Publication Date
CA1177420A true CA1177420A (fr)	1984-11-06

Family

ID=27166729

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000423778A Expired CA1177420A (fr)	1980-05-08	1983-03-16	Vehicules de clonage

Country Status (1)

Country	Link
CA (1)	CA1177420A (fr)

1983
- 1983-03-16 CA CA000423778A patent/CA1177420A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2001-11-06	MKEX	Expiry

Publication	Publication Date	Title
Olsen et al.	1982	Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome
Mann et al.	1978	Cloning of restriction and modification genes in E. coli: the HhaII system from Haemophilus haemolyticus
Timmis et al.	1978	Cloning and characterization of Eco RI and Hin dIII restriction endonuclease-generated fragments of antibiotic resistance plasmids R6-5 and R6
Bradley	1984	Characteristics and function of thick and thin conjugative pili determined by transfer-derepressed plasmids of incompatibility groups I1, I2, I5, B, K and Z
Lecadet et al.	1980	Generalized transduction in Bacillus thuringiensis var. berliner 1715 using bacteriophage CP-54Ber
US4375514A (en)	1983-03-01	Preparation and use of recombinant plasmids containing genes for alkaline phosphatases
JPH0691827B2 (ja)	1994-11-16	新規ベクタ−プラスミド
GB2048894A (en)	1980-12-17	Plasmid
CA1150169A (fr)	1983-07-19	Anneaux de plasmides comme vehicule de clonage
EP0060663A2 (fr)	1982-09-22	Procédé pour la transformation de certains micro-organismes, vecteurs et leur production, et procédé pour la production de certaines substances utilisant les vecteurs precités
US4360597A (en)	1982-11-23	Streptomyces plasmid and culture
FR2559781A1 (fr)	1985-08-23	Nouveau vecteur plasmidique hybride de e. coli conferant le pouvoir de faire fermenter le saccharose et son procede de preparation
Morgan et al.	1988	Genetic organization and regulation of proteins associated with production of syringotoxin by Pseudomonas syringae pv. syringae
US4376164A (en)	1983-03-08	Process for preparing broad host range small plasmid rings as cloning vehicles
EP0091723A2 (fr)	1983-10-19	Système de vecteur
Foster et al.	1976	Genetic Analysis of Deletions of R1001 that are Both Transfer-deficient and Tetracycline-sensitive
US4418194A (en)	1983-11-29	DNA Fragments for forming plasmids
US4717666A (en)	1988-01-05	Cloned streptomycete lividans excretable β-galactosidase gene
Cowman et al.	1980	Molecular cloning of the gene (ush) from Escherichia coli specifying periplasmic UDP-sugar hydrolase (5'-nucleotidase)
JPS62122585A (ja)	1987-06-03	宿主・ベクタ−系
US4686184A (en)	1987-08-11	Gene transfer vector
US5049501A (en)	1991-09-17	Production method for PvuI restriction endonuclease
EP0179025A1 (fr)	1986-04-23	Méthode de production de protéase neutre
KR870001127B1 (ko)	1987-06-09	미생물의 유전적 변형방법
JP2949352B2 (ja)	1999-09-13	プラスミド▲下ｐ▼ＮＩ２０及びそれをベクターとして用いた遺伝子組換え法